Sens. Susan Collins (R-ME) and Amy Klobuchar (D-MN) and 10 other senators, in a bipartisan letter Friday, urged President Donald Trump to increase current funding for Alzheimer’s disease research...
Omnibus bill includes $3.1 billion for dementia research
By
Lois A. Bowers
Dec 22, 2020
The $1.4 trillion appropriations omnibus spending bill advanced by congressional leaders on Monday includes an increase of more than $300 million in funding for dementia research at the National Institutes...
Master Plan for Aging adds dementia screening tool for providers
By
Lois A. Bowers
Apr 17, 2023
Primary care providers in the country’s most populous state have a new screening tool to help them identify cognitive decline in older adults and determine next steps.
CDC data show how small, large assisted living communities differ
By
Lois A. Bowers
Feb 07, 2018
A data brief published Tuesday by the Centers for Disease Control and Prevention’s National Center for Health Statistics sheds light on the differences between smaller and larger assisted living...
Lawmakers chide HHS for ‘eroding the pathway’ to Alzheimer’s treatments
By
Kimberly Bonvissuto
Mar 24, 2023
With personal stories of the effects that Alzheimer’s disease has had on them, lawmakers in a Senate Finance Committee hearing on Wednesday called for the federal government to speed up access to treatments....
Inconsistent state regulations, staff training produce wide variations among states’ antipsychotic...
By
Kimberly Bonvissuto
Feb 28, 2023
Researchers are calling for a closer look at the use of antipsychotics among assisted living residents with dementia after a study found wide variations in prescribing patterns.
The Department of Health and Human Services is extending until Aug. 28 the deadline for eligible state Medicaid providers, including assisted living operators, to apply for monies from the Coronavirus...
Pharmaceutical company to pay $96 million to settle claims of promoting unapproved use of drug for dementia...
By
Lois A. Bowers
Sep 27, 2019
Pharmaceutical company Avanir has agreed to pay $96 million to resolve federal False Claims Act allegations that it paid kickbacks and marketed the drug Nuedexta in long-term care communities for the off-label...
Bipartisan group of 23 state AGs joins call for unrestricted coverage of Alzheimer’s treatments
By
Kimberly Bonvissuto
May 03, 2023
A bipartisan group of attorneys general from 23 states have joined a growing chorus calling on Medicare to reverse a previous decision and provide unrestricted coverage of Food and Drug Administration-approved...
Dementia to cost nation $321 billion this year, Alzheimer’s Association says
By
Kimberly Bonvissuto
Mar 16, 2022
This year, Alzheimer’s and other dementias will cost the nation $321 billion, increasing to $1 trillion by 2050, according to a report released Tuesday by the Alzheimer’s Association.